SERPINF1 and neoplasm: Konson et al. [103] showed that a triple phosphomimetic-altered PEDF is more efficient than wild-type PEDF in blocking neovascularization and tumor growth in vivo, and that this altered protein suppresses cultured endothelial cell proliferation much more effectively than wild-type PEDF.